title: [Substantiation of the duration of m-cholinolytics administration in conservative treatment of hyperactive urinary bladder].
abstract: The analysis of treatment outcomes in 74 patients with hyperactive urinary bladder (HUB) has shown that duration of the treatment depends on the initial function of the lower urinary tracts. There was a correlation between mean effective therapy and treatment duration. Estimation of this correlation allows prognosis of treatment efficacy and selection of optimal anticholinergic drug for correction of miction disorders. Spasmex proved to be the most adequate drug for long-term treatment due to minimal number of side effects and feasibility to vary dose and regimen of intake.
authors: V V
authors: VV
authors: Danilov
authors: I Iu
authors: IIu
authors: Vol'nykh
authors: T I
authors: TI
authors: Danilova
authors: O A
authors: OA
authors: Vodop'ianova
authors: N A
authors: NA
authors: Kudriakova
mesh_terms: D016208:Databases, Factual; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008499:Medical Records; D018727:Muscarinic Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use; D011788:Quality of Life; D013997:Time Factors; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000503:physiopathology; D014554:Urination / Q000187:drug effects*; D014563:Urodynamics / Q000187:drug effects*
chemical_list: D018727:Muscarinic Antagonists